Background
Methods
Patients
Operation procedures
Statistical analysis
Results
Clinicopathological characteristics
Variables | All Patients | Patients after PSM | ||||
---|---|---|---|---|---|---|
RATG(n = 126) | LATG(n = 257) | p | RATG(n = 126) | LATG(n = 126) | p | |
Age, year (mean ± SD) | 60.33 ± 8.94 | 58.26 ± 10.41 | 0.051 | 60.33 ± 8.94 | 60.78 ± 9.05 | 0.690 |
Sex (male/female) | 105/21 | 197/60 | 0.133 | 105/21 | 100/26 | 0.419 |
Height, cm (mean ± SD) | 163.52 ± 6.58 | 162.74 ± 7.25 | 0.304 | 163.52 ± 6.58 | 162.79 ± 7.91 | 0.422 |
Weight, Kg (mean ± SD) | 59.21 ± 8.37 | 59.63 ± 9.46 | 0.667 | 59.21 ± 8.37 | 58.84 ± 9.70 | 0.745 |
BMI, Kg/m2(mean ± SD) | 22.10 ± 2.48 | 22.46 ± 2.93 | 0.200 | 22.10 ± 2.48 | 22.13 ± 2.84 | 0.929 |
ASA (I/II/III) | 87/36/3 | 185/68/4 | 0.529 | 87/36/3 | 94/30/2 | 0.320 |
Tumor size, cm (mean ± SD) | 4.62 ± 2.22 | 4.55 ± 2.28 | 0.759 | 4.62 ± 2.22 | 4.40 ± 2.35 | 0.446 |
Tumor location | 0.398 | 0.661 | ||||
Siewert type II | 28 | 61 | 28 | 28 | ||
Siewert type III | 30 | 69 | 30 | 33 | ||
Body | 68 | 127 | 68 | 65 | ||
Borrmann type | 0.076 | 0.785 | ||||
I/II/III/IV | 3/11/100/12 | 11/27/207/12 | 3/11/100/12 | 2/10/106/8 | ||
Depth of infiltration (T) | 0.023 | 0.796 | ||||
T2 | 7 | 36 | 7 | 9 | ||
T3 | 2 | 3 | 2 | 1 | ||
T4a | 117 | 218 | 117 | 116 | ||
Nodal status (N) | 0.483 | 0.841 | ||||
N0 | 29 | 64 | 29 | 30 | ||
N1 | 29 | 45 | 29 | 25 | ||
N2 | 27 | 43 | 27 | 25 | ||
N3a | 21 | 61 | 21 | 29 | ||
N3b | 20 | 44 | 20 | 17 | ||
TNM stage | 0.814 | 0.803 | ||||
IB | 3 | 23 | 3 | 3 | ||
IIA | 6 | 7 | 6 | 0 | ||
IIB | 24 | 44 | 24 | 27 | ||
IIIA | 52 | 81 | 52 | 45 | ||
IIIB | 21 | 58 | 21 | 31 | ||
IIIC | 20 | 44 | 20 | 10 | ||
Differentiation | 0.006 | 0.534 | ||||
G1/G2/G3 | 0/28/98 | 1/92/164 | 0/28/98 | 0/24/102 | ||
Comorbidities (0/1/2/3) | 91/23/6/6 | 174/52/25/6 | 0.385 | 91/23/6/6 | 91/22/11/2 | 0.983 |
Abdominal surgery history (Y/N) | 5/121 | 26/231 | 0.038 | 5/121 | 13/113 | 0.050 |
Short-term surgical outcomes of the cohorts
Variables | All Patients | Patients after PSM | ||||
---|---|---|---|---|---|---|
RATG(n = 126) | LATG(n = 257) | p | RATG(n = 126) | LATG(n = 126) | p | |
Operation time, min (mean ± SD) | 291.14 ± 59.18 | 270.27 ± 49.41 | 0.003 | 291.14 ± 59.18 | 270.34 ± 52.22 | 0.003 |
Bleeding, ml (mean ± SD) | 154.37 ± 89.68 | 175.19 ± 105.44 | 0.028 | 154.37 ± 89.68 | 183.77 ± 95.39 | 0.004 |
Retrieved lymph nodes (mean ± SD) | 34.90 ± 13.05 | 32.02 ± 12.41 | 0.037 | 34.90 ± 13.05 | 31.91 ± 12.46 | 0.065 |
N1 tier (mean ± SD) | 25.83 ± 10.68 | 24.41 ± 10.09 | 0.206 | 25.83 ± 10.68 | 24.36 ± 10.00 | 0.261 |
N2 tier (mean ± SD) | 9.07 ± 5.34 | 7.61 ± 4.57 | 0.007 | 9.07 ± 5.34 | 7.56 ± 4.50 | 0.016 |
Length of incision, cm (mean ± SD) | 6.32 ± 1.58 | 6.34 ± 1.75 | 0.546 | 6.32 ± 1.58 | 6.46 ± 1.87 | 0.914 |
Proximal margin, cm (mean ± SD) | 3.55 ± 1.69 | 3.67 ± 1.43 | 0.488 | 3.55 ± 1.69 | 3.67 ± 1.53 | 0.553 |
Distal margin, cm (mean ± SD) | 7.14 ± 3.68 | 7.59 ± 3.79 | 0.275 | 7.14 ± 3.68 | 7.72 ± 3.83 | 0.225 |
R0/R1 | 116/10 | 244/13 | 0.265 | 116/10 | 118/8 | 0.625 |
Postoperative hospital stay, d (mean ± SD) | 9.62 ± 2.86 | 9.93 ± 4.00 | 0.430 | 9.62 ± 2.86 | 9.86 ± 4.31 | 0.606 |
Variables | All Patients | Patients after PSM | ||||
---|---|---|---|---|---|---|
RATG(n = 126) | LATG(n = 257) | p | RATG(n = 126) | LATG(n = 126) | p | |
Present/absent | 30/96 (23.8%) | 75/182 (29.2%) | 0.268 | 30/96 (23.8%) | 36/90 (28.6%) | 0.390 |
Clavien-Dindo Classification | ||||||
I | 3 (2.4%) | 11 (4.3%) | 0.352 | 3 (2.4%) | 7 (5.6%) | 0.197 |
Wound problem | 2 | 5 | 2 | 2 | ||
Fever | 1 | 5 | 1 | 3 | ||
Cardiac dysfunction | 0 | 2 | 0 | 2 | ||
Diarrhea | 0 | 2 | 0 | 1 | ||
Chylous leakage | 0 | 1 | 0 | 1 | ||
II | 20 (15.9%) | 43 (16.7%) | 0.831 | 20 (15.9%) | 22 (17.5%) | 0.735 |
Fever | 5 | 4 | 5 | 3 | ||
Wound infection | 0 | 1 | 0 | 1 | ||
Intra-abdominal infection | 2 | 7 | 2 | 4 | ||
Intestinal obstruction | 1 | 0 | 1 | 0 | ||
Catheter infections | 4 | 1 | 4 | 1 | ||
Pulmonary infection | 8 | 21 | 8 | 11 | ||
Pulmonary atelectasis | 0 | 4 | 0 | 0 | ||
Pleural effusion | 3 | 10 | 3 | 4 | ||
Anastomotic leakage | 2 | 6 | 2 | 1 | ||
Anastomotic stenosis | 2 | 1 | 2 | 0 | ||
Intra-abdominal bleeding | 1 | 2 | 1 | 2 | ||
Duodenal stump leakage | 0 | 2 | 0 | 1 | ||
Cardiac dysfunction | 0 | 2 | 0 | 1 | ||
IIIa | 2 (1.6%) | 9 (3.5%) | 0.466 | 2 (1.6%) | 3 (2.4%) | 1.000 |
Wound problem | 0 | 2 | 0 | 1 | ||
Duodenal stump leakage | 1 | 0 | 1 | 0 | ||
Anastomotic leakage | 0 | 3 | 0 | 1 | ||
Pleural effusion | 1 | 6 | 1 | 2 | ||
Pyothorax | 0 | 1 | 0 | 0 | ||
Intra-abdominal infection | 0 | 5 | 0 | 2 | ||
IIIb | 2 (1.6%) | 4 (1.6%) | 1.000 | 2 (1.6%) | 0 (0%) | 0.478 |
Intra-abdominal bleeding | 1 | 1 | 1 | 0 | ||
Anastomotic bleeding | 0 | 1 | 0 | 0 | ||
Duodenal stump leakage | 0 | 1 | 0 | 0 | ||
Anastomotic leakage | 1 | 1 | 1 | 0 | ||
IVa | 2 (1.6%) | 4 (1.6%) | 1.000 | 2 (1.6%) | 2 (1.6%) | 1.000 |
Respiratory failure | 2 | 3 | 2 | 1 | ||
Cardiac failure | 0 | 1 | 0 | 1 | ||
IVb | 0 (0%) | 3 (1.2%) | 0.554 | 0 (0%) | 1 (0.8%) | 1.000 |
MODS | 0 | 3 | 0 | 1 | ||
V | 1 (0.8%) | 1 (0.4%) | 0.550 | 1 (0.8%) | 1 (0.8%) | 1.000 |
Clavien-Dindo grade ≥ IIIa | 7 (5.6%) | 21 (8.2%) | 0.356 | 7 (5.6%) | 7 (5.6%) | 1.000 |
Mortality | 1 (0.8%) | 1 (0.4%) | 0.550 | 1 (0.8%) | 1 (0.8%) | 1.000 |
Stratified analysis of different related factors
Location EGJ | Location non-EGJ | |||||
---|---|---|---|---|---|---|
RATG(n = 58) | LATG(n = 61) | p | RATG(n = 68) | LATG(n = 65) | p | |
Age | 61.64 ± 8.57 | 62.41 ± 7.80 | 0.608 | 59.21 ± 9.16 | 59.25 ± 9.89 | 0.981 |
Sex (male/female) | 50/8 | 51/10 | 0.692 | 55/13 | 49/16 | 0.443 |
BMI (kg/m2) | 22.90 ± 2.38 | 22.45 ± 2.82 | 0.344 | 21.41 ± 2.37 | 21.82 ± 2.84 | 0.359 |
Tumor size (cm) | 3.66 ± 1.53 | 4.10 ± 1.51 | 0.121 | 5.44 ± 2.39 | 4.69 ± 2.91 | 0.106 |
TNM (IB/IIA/IIB/IIIA/IIIB/IIIC) | 2/1/12/27/11/5 | 1/1/10/29/12/8 | 0.350 | 1/5/12/25/10/15 | 7/0/12/21/16/9 | 0.611 |
Comorbidities (present/absent) | 18/40 | 11/50 | 0.099 | 17/51 | 24/41 | 0.137 |
Operation time (min) | 287.98 ± 51.97 | 273.07 ± 49.62 | 0.113 | 293.84 ± 64.95 | 267.78 ± 54.80 | 0.014 |
Estimated blood loss (ml) | 134.66 ± 58.83 | 173.93 ± 89.41 | 0.011 | 171.18 ± 106.95 | 193.00 ± 100.49 | 0.085 |
No. of N2 tier | 8.79 ± 4.86 | 7.43 ± 3.84 | 0.091 | 9.31 ± 5.75 | 7.68 ± 5.07 | 0.085 |
No. of Retrieved lymph nodes | 35.43 ± 13.38 | 33.36 ± 11.68 | 0.184 | 34.44 ± 12.84 | 31.49 ± 13.23 | 0.194 |
R0/R1 | 52/6 | 56/5 | 0.686 | 64/4 | 62/3 | 1.000 |
Proximal margin (cm) | 2.12 ± 0.99 | 2.58 ± 1.08 | 0.013 | 4.77 ± 1.11 | 4.69 ± 1.14 | 0.682 |
Postoperative complication (%) | 18 (31.0) | 15 (24.6) | 0.433 | 12 (17.6) | 17 (26.2) | 0.235 |
Clavien-Dindo grade ≥ IIIa (%) | 5 (8.6) | 1 (1.6) | 0.187 | 2 (2.9) | 6 (9.2) | 0.246 |
Postoperative hospital stay (d) | 9.90 ± 2.77 | 9.31 ± 1.85 | 0.176 | 9.38 ± 2.93 | 10.37 ± 5.71 | 0.914 |
Size≥5 cm | Size< 5 cm | |||||
---|---|---|---|---|---|---|
RATG(n = 56) | LATG(n = 43) | p | RATG(n = 70) | LATG(n = 83) | p | |
Age | 61.77 ± 8.23 | 60.47 ± 8.09 | 0.433 | 59.17 ± 9.37 | 60.94 ± 9.55 | 0.251 |
Sex (male/female) | 45/11 | 34/9 | 0.874 | 60/10 | 66/17 | 0.317 |
BMI (kg/m2) | 21.74 ± 2.34 | 22.52 ± 3.20 | 0.218 | 22.38 ± 2.57 | 21.92 ± 2.62 | 0.277 |
Tumor location (non-EGJ/EGJ) | 39/17 | 23/20 | 0.100 | 29/41 | 41/42 | 0.324 |
TNM (IB/IIA/IIB/IIIA/IIIB/IIIC) | 3/2/8/20/11/12 | 1/0/8/17/9/8 | 0.959 | 0/4/16/32/10/8 | 7/1/14/33/19/9 | 0.950 |
Comorbidities (present/absent) | 17/39 | 13/30 | 0.989 | 18/52 | 22/61 | 0.912 |
Operation time (min) | 287.46 ± 56.87 | 278.33 ± 55.51 | 0.425 | 294.09 ± 61.20 | 266.20 ± 50.27 | 0.002 |
Estimated blood loss (ml) | 159.82 ± 75.14 | 198.95 ± 110.76 | 0.132 | 150.00 ± 100.13 | 175.90 ± 86.03 | 0.087 |
No. of N2 tier | 8.64 ± 4.63 | 8.14 ± 4.78 | 0.599 | 9.41 ± 5.86 | 7.25 ± 4.35 | 0.010 |
No. of Retrieved lymph nodes | 36.70 ± 13.18 | 33.14 ± 11.66 | 0.165 | 33.46 ± 12.86 | 31.28 ± 12.88 | 0.298 |
R0/R1 | 53/3 | 40/3 | 1.000 | 63/7 | 78/5 | 0.362 |
Proximal margin (cm) | 3.96 ± 1.62 | 3.85 ± 1.37 | 0.708 | 3.21 ± 1.69 | 3.57 ± 1.61 | 0.179 |
Postoperative complication (%) | 15 (26.8) | 16 (37.2) | 0.268 | 15 (21.4) | 20 (24.1) | 0.696 |
Clavien-Dindo grade ≥ IIIa(%) | 2 (3.6) | 4 (9.3) | 0.447 | 5 (7.1) | 3 (3.6) | 0.540 |
Postoperative hospital stay (d) | 9.61 ± 1.99 | 10.58 ± 5.13 | 0.951 | 9.63 ± 3.41 | 9.48 ± 3.80 | 0.804 |
Age ≥ 65ys | Age < 65ys | |||||
---|---|---|---|---|---|---|
RATG(n = 47) | LATG(n = 44) | p | RATG(n = 79) | LATG(n = 82) | p | |
Sex (male/female) | 42/5 | 37/7 | 0.458 | 63/16 | 63/19 | 0.654 |
BMI (kg/m2) | 22.54 ± 2.69 | 21.69 ± 2.68 | 0.137 | 21.83 ± 2.32 | 22.36 ± 2.90 | 0.214 |
Tumor location (non-EGJ/EGJ) | 20/27 | 22/22 | 0.476 | 48/31 | 43/39 | 0.287 |
Tumor size (cm) | 4.39 ± 2.05 | 4.48 ± 2.70 | 0.868 | 4.76 ± 2.31 | 4.36 ± 2.16 | 0.263 |
TNM (IB/IIA/IIB/IIIA/IIIB/IIIC) | 2/3/4/17/11/10 | 4/1/6/15/11/7 | 0.503 | 1/3/20/35/10/10 | 4/0/16/35/17/10 | 0.340 |
Comorbidities (present/absent) | 14/33 | 18/26 | 0.267 | 21/58 | 17/65 | 0.382 |
Operation time (min) | 291.70 ± 71.98 | 259.98 ± 49.99 | 0.017 | 290.81 ± 50.55 | 275.90 ± 52.83 | 0.069 |
Estimated blood loss (ml) | 161.81 ± 94.15 | 174.20 ± 90.68 | 0.524 | 149.94 ± 87.23 | 188.90 ± 97.98 | 0.037 |
No. of N2 tier | 9.19 ± 6.45 | 7.41 ± 4.18 | 0.124 | 9.00 ± 4.61 | 7.63 ± 4.69 | 0.012 |
No. of Retrieved lymph nodes | 34.79 ± 13.33 | 33.02 ± 12.29 | 0.514 | 34.96 ± 12.96 | 31.32 ± 12.59 | 0.072 |
R0/R1 | 42/5 | 39/5 | 1.000 | 72/5 | 79/3 | 0.650 |
Proximal margin (cm) | 3.22 ± 1.57 | 3.61 ± 1.44 | 0.221 | 3.74 ± 1.74 | 3.70 ± 1.59 | 0.870 |
Postoperative complication (%) | 14 (29.8) | 14 (31.8) | 0.834 | 16 (20.3) | 22 (26.8) | 0.326 |
Clavien-Dindo grade ≥ IIIa (%) | 3 (6.4) | 1 (2.3) | 0.657 | 4 (5.1) | 6 (7.3) | 0.554 |
Postoperative hospital stay (d) | 9.79 ± 2.81 | 10.34 ± 4.98 | 0.512 | 9.52 ± 2.92 | 9.60 ± 3.92 | 0.885 |